Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia
about
Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathologyGlial contributions to neurodegeneration in tauopathies.Association of gray matter atrophy with age, β-amyloid, and cognition in agingAPOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burdenAPOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age MattersAdverse Effects of the Apolipoprotein E ε4 Allele on Episodic Memory, Task Switching and Gray Matter Volume in Healthy Young AdultsApolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's diseaseInteractive effects of apolipoprotein E type 4 genotype and cerebrovascular risk on neuropsychological performance and structural brain changes.A non-invasive, rapid method to genotype late-onset Alzheimer's disease-related apolipoprotein E gene polymorphismsNeural compensation in older people with brain amyloid-β deposition.Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseasesβ-Amyloid affects frontal and posterior brain networks in normal aging.Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases.ApoE E4 is a susceptibility factor in amnestic but not aphasic dementias.Intracranial volume and dementia: some evidence in support of the cerebral reserve hypothesis.Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age.COMT Val158Met genotype influences neurodegeneration within dopamine-innervated brain structures.Regionally selective atrophy after traumatic axonal injuryEffects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional VulnerabilityBrain tissue volumes by APOE genotype and leisure activity-the AGES-Reykjavik Study.ApoE and TDP-43 neuropathology in two siblings with familial FTLD-motor neuron disease.Surface fluid registration of conformal representation: application to detect disease burden and genetic influence on hippocampusApolipoprotein e sets the stage: response to injury triggers neuropathology.Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations.Anti-saccade performance predicts executive function and brain structure in normal elders.Clinical Characteristics of C9ORF72-Linked Frontotemporal Lobar DegenerationMolecular nexopathies: a new paradigm of neurodegenerative disease.Antisaccade task reflects cortical involvement in mild cognitive impairmentA Triple Network Connectivity Study of Large-Scale Brain Systems in Cognitively Normal APOE4 Carriers.Using the Disease State Fingerprint Tool for Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease.Frontotemporal network connectivity during memory encoding is increased with aging and disrupted by beta-amyloid.APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain.APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory.Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.Apolipoprotein E in Alzheimer's disease and other neurological disorders.Gray matter atrophy in behavioral variant frontotemporal dementia: a meta-analysis of voxel-based morphometry studies.The paradox of syndromic diversity in Alzheimer disease.Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.Apolipoprotein E genotype modulates effects of vitamin B12 and homocysteine on grey matter volume in Alzheimer's disease.
P2860
Q30421643-DEF6A095-BFA4-4BBD-90F5-525350E81DC5Q32173558-BE149538-2A21-4B1D-918B-45F2A9C927D0Q33582714-B5536393-E081-4BBA-B480-2EFBCF3C3E2DQ33690208-2B87B9D1-4B65-4793-9111-570F152DBBCAQ33803956-DA642F52-1AE2-4DF2-B49B-6976C4F68CB6Q33822745-FC5DA5E7-8909-4A1A-AD22-F1C01B9A3239Q33849832-B9DC653A-C349-4B99-AED3-50D53F3F0065Q33933382-529AAC78-D50D-4DC1-BF1B-1A2A87A272A7Q33976938-BF585A92-3EB0-4B4A-862D-B2854AE2ED3CQ34096343-C09E966F-ACF7-4F49-8EC4-1E734C3B2426Q34253028-FD687C60-CC3C-472C-8363-07FB0C1C07A3Q34546133-4291DAE2-1024-48AE-A7FC-22D0E9214053Q34572447-4D47A986-8832-4E97-87EE-2E97CB156C2DQ34621541-2099EB3B-F279-483E-A016-1530E2C67689Q35000246-268C1E67-632E-4401-B7E2-6BFAF4CFF054Q35697954-4E92F291-5D45-4DBB-8FA1-9499AD612731Q35825830-7479BB68-4D7D-4DDE-8124-5E739A66CBB0Q35985557-49603E1B-85C1-4AD1-ADDB-ADD2049D8561Q36300223-04040CDD-D52F-4777-ACDF-0A17AB547C53Q36462403-3F37D80D-C2BB-474E-BD9B-315546EB0544Q36767483-D8981A9F-2DD2-4765-B75C-60DD694E04B9Q36847301-76EA88B4-5651-4A3F-B5E9-D0A0B63CEA9DQ36932677-686D78D7-27D6-4341-866B-299C85945CD5Q36963238-2ACFD480-6A40-4ACB-978B-83B394BEA00BQ37170650-8D0B3A83-2AFA-49A0-A9B4-FD239A820C42Q37178137-AD8CB1CF-08A3-445C-AA7B-8BB051835CCCQ37180721-7A4C2FE5-BBF6-4C24-856F-9399381C9FB3Q37223726-12E5D87B-5448-42D5-9EA5-CB61A1E274BAQ37227071-08F397F8-437A-4942-9E1E-D07FD14A320DQ37290059-B6B3505E-1C1F-459E-A2C3-E33019CFFCF8Q37293722-20924CA5-1E79-4C79-A979-8D6A96CDE3A5Q37325366-FC24074E-1135-495E-8CA4-606475522F78Q37459037-C0FD15DA-6D75-4FBE-A481-98AA31423BEBQ37623222-2C75010B-37F3-49E8-9F05-38CABDA359FBQ37639155-D39BE522-A93F-4EC5-89AC-2884E5A37F33Q37846932-11527CC3-070A-4B87-85B5-B9058AF02807Q38020748-A9956DC9-7EDB-4CEF-8713-1F16B694B824Q38026786-E0B233E6-CEC0-4434-9258-BAB0C8F625F5Q38082670-240DF79F-18D4-42D4-BA9E-AEBD75AB7B03Q38426572-26FB0580-9AA0-4092-AEDC-5B2FC023BD0A
P2860
Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Apolipoprotein E epsilon4 is a ...... se and frontotemporal dementia
@en
Apolipoprotein E epsilon4 is a ...... e and frontotemporal dementia.
@nl
type
label
Apolipoprotein E epsilon4 is a ...... se and frontotemporal dementia
@en
Apolipoprotein E epsilon4 is a ...... e and frontotemporal dementia.
@nl
prefLabel
Apolipoprotein E epsilon4 is a ...... se and frontotemporal dementia
@en
Apolipoprotein E epsilon4 is a ...... e and frontotemporal dementia.
@nl
P2093
P2860
P50
P356
P1476
Apolipoprotein E epsilon4 is a ...... se and frontotemporal dementia
@en
P2093
Anna Karydas
Federica Agosta
Katherine L Possin
Keith A Vossel
Massimo Filippi
Raffaella Migliaccio
P2860
P304
P356
10.1073/PNAS.0812697106
P407
P577
2009-01-22T00:00:00Z